Watch the latest Alzheimer’s Disease programs from the Brain Channel:
Embracing Innovation: Discovering New Drugs for Alzheimer’s Disease
How can we create more effective drugs for Alzheimer’s disease? Michael Jackson, PhD joins William Mobley, MD, PhD to discuss the process of turning an idea into a drug. Creating connectivity between basic scientists, pharmaceutical companies, and the physicians on the front lines is a critical step as is embracing new ideas that may lead us to new therapeutic options.
Seeking the Biomarkers of Alzheimer’s Disease
The biomarkers for many diseases can be found through blood tests, can Alzheimer’s disease eventually be diagnosed this way? Douglas R. Galasko, MD joins William Mobley, MD, PhD to discuss the search for these biomarkers and how they might one day lead to earlier and more accurate diagnoses of the disease, improved therapies, clear maps of progression, and much more.
The Brain Channel’s flagship series On Our Mind takes a closer look at Alzheimer’s disease. Join Dr. William Mobley as he meets with those on the front lines of this disease to discuss current and potential therapies, testing, clinical trials, neuropathology, public policy and so much more.
Watch the latest Alzheimer’s Disease programs from the Brain Channel!
The Brain Channel’s flagship series On Our Mind is endeavoring in the next few months to take a closer look at Alzheimer’s disease. Join Dr. William Mobley as he meets with those on the front lines of this disease to discuss current and potential therapies, testing, clinical trials, neuropathology, public policy and so much more.
Diagnosing Alzheimer’s Disease
How do you know when memory problems become more than just problems? Diagnosing Alzheimer’s disease can be challenging but new tests and scientific insight are making the process simpler and more accurate. Michael Rafii, MD, PhD joins William Mobley, MD, PhD to discuss when to see a doctor, what to expect during the diagnosis process, and other valuable information for patients and their families.
Developing New Drugs for Alzheimer’s Disease
What does the future hold for the treatment of Alzheimer’s disease? Steven L. Wagner, PhD joins William Mobley, MD, PhD to discuss the development of new drugs to aid in the fight. Wagner describes amyloid plaques as “the cholesterol of the brain” and is working to find a way to suppress its adverse effects.
Down Syndrome and Alzheimer’s Disease
By the age of 40, nearly all people with Down syndrome have the plaques and tangles associated with Alzheimer’s disease. Michael Rafii, MD, PhD joins William Mobley, MD, PhD to discuss why this occurs, the prevalence and progression of Alzheimer’s disease, potential treatment models and current research affecting this predisposed population.
Detecting Alzheimer’s Disease Earlier and Effectively
Early detection of Alzheimer’s disease – before symptoms are visible – may be a key to stopping the disease’s progression. What warning signs are researchers looking for and what tools can they use? Paul Aisen, MD joins William Mobley, MD, PhD to discuss optimal assessments for diagnosing the disease, novel tools making earlier diagnosis possible, and the road map to developing drugs to slow, halt, and prevent Alzheimer’s.
Dementia is a deterioration of cognitive function that begins with mild cognitive impairment, which appears just like forgetfulness, and eventually ends in death.
There are many causes of the disease such as stroke, chronic alcohol abuse and Alzheimer’s but there is no way to reverse the damage of the brain’s degeneration.
Dr. Mario D. Garrett of San Diego State University’s School of Social Work discusses the social impacts of dementia, such as the way dementia is classified by institutions and even the errors he has found in the way dementia is perceived.
Composer Anthony Davis presents a modern take on Shakespeare’s classic, King Lear.
Lear on the 2nd Floor tells the story of Nora Lear, a neuroscience researcher suffering from early-onset Alzheimer’s. As Nora loses her bearings and autonomy, she is increasingly at the mercy of her three quarreling daughters. In this version, Nora’s dead husband Mortimer is Shakespeare’s fool and her constant companion, as she wanders through a world where past and present blend and reality bends.
Davis’s music incorporates diverse styles and influences, ranging from classical opera to jazz to reggae. This performance by UC San Diego’s Kallisti Vocal Ensemble includes various music styles from classical opera to reggae, as well as a libretto by playwright Allan Havis.
In April, President Obama called for the BRAIN (Brain Research through Advancing Innovative Neurotechnologies) Initiative, a research effort aimed at revealing some of the mysteries of the human brain.
The inner functioning of the brain is something we are only just beginning to understand and with each new revelation comes the immense complexity of the brain’s sophistication.
In Communicating Brains: From Autism and Dyslexia to Progressive Aphasia, Elysa Marco, Nina Dronkers and Maya Henry study disorders, such as autism, dyslexia, and aphasia to better understand the processes a healthy brain uses to communicate. Each disorder affects the brain differently revealing a different way the brain processes can be disrupted, thus divulging more about those communicative functions.